Hormones and the blood-brain barrier

Hormone Molecular Biology and Clinical Investigation

Volumn 21, Issue 3, 2015, Pages 159-164

  Hampl, Richard ^a   Bičíková, Marie ^a   Sosvorová, Lucie ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

blood brain barrier; hormones; permeability; protein transporters; transport

Indexed keywords

CYTOKINE; GROWTH HORMONE; HORMONE; INSULIN; NEUROSTEROID; PEPTIDE HORMONE; SOMATOMEDIN C; STEROID; THYROID HORMONE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; ENDOTHELIUM CELL; HORMONE TRANSPORT; HUMAN; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; TIGHT JUNCTION; BRAIN; CYTOLOGY; METABOLISM; PERMEABILITY;

BLOOD-BRAIN BARRIER; BRAIN; ENDOTHELIAL CELLS; HORMONES; HUMANS; PERMEABILITY;

EID: 84928649061     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2014-0042     Document Type: Article

References (46)

1. Tajes M, Ramos-Fernández E, Weng-Jiang X, Bosch-Morató M, Guivernau B, Eraso-Pichot A, Salvador B, Fernández-Busquets X, Roquer J, Muñoz FJ. The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol Membr Biol 2014;31:152-67.
2. Liebner S, Czupalla CJ, Wolburg H. Current concepts of bloodbrain barrier development. Int J Dev Biol 2011;55:467-76.
3. Keller A. Breaking and building the wall: the biology of the blood-brain barrier in health and disease. Swiss Med Wkly 2013;143:w13892.
4. Greenwood J, Heasman SJ, Alvarez JI, Prat A, Lyck R, Engelhardt B. Review: leucocyte-endothelial cell crosstalk at the bloodbrain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol 2011;37:24-39.
5. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004;16:1-13.
6. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37:13-25.
7. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000;27:422-7.
8. Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev 2007;56:119-47.
9. Lossinsky AS, Shivers RR. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Histol Histopathol 2004;19:535-64.
10. Jia W, Martin TA, Zhang G, Jiang WG. Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. Anticancer Res 2013;33:2353-9.
11. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-85.
12. Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in bloodbrain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther 2012;18:609-15.
13. Banks WA. Brain meets the body: the blood-brain barrier as an endocrine interface. Endocrinology 2012;153:4111-9.
14. Go KG. The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg 1997;23:47-142.
15. Barros LF, Bittner CX, Loaiza A, Porras OH. A quantitative overview of glucose dynamics in the gliovascular unit. Glia 2007;55:1222-37.
16. Hawkins RA1, O'Kane RL, Simpson IA, Viña JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 2006;136 (1 Suppl):218S-26S.
17. Smith QR. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 2000;130(4S Suppl 1):1016S-22S.
18. Wang H, Eckel RH. What are lipoproteins doing in the brain? Trends Endocrinol Metab 2014;25:8-14.
19. Banks WA. Delivery of peptides to the brain: emphasis on therapeutic development. Biopolymers 2008;90:589-94.
20. Shen S, Zhang W. ABC transporters and drug efflux at the bloodbrain barrier. Rev Neurosci 2010;21:29-53.
21. Löscher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2005;2:86-98.
22. Jedlitschky G, Grube M, Mosyagin I, Kroemer HK, Vogelgesang S. Targeting CNS transporters for treatment of neurodegenerative diseases. Curr Pharm Des 2014;20:1523-33.
23. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003;1609:1-18.
24. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 1997;52:1-32.
25. Kríz L, Bicíková M, Hampl R. Roles of steroid sulfatase in brain and other tissues. Physiol Res 2008;57:657-68.
26. Asaba H, Hosoya K, Takanaga H, Ohtsuki S, Tamura E, Takizawa T, Terasaki T. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. J Neurochem 2000;75:1907-16.
27. Jeitner TM, Voloshyna I, Reiss AB. Oxysterol derivatives of cholesterol in neurodegenerative disorders. Curr Med Chem 2011;18:1515-25.
28. Björkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006;260:493-508.
29. Wirth EK, Schweizer U, Köhrle J. Transport of thyroid hormone in brain. Front Endocrinol (Lausanne) 2014;5:98.
30. Blay P, Nilsson C, Owman C, Aldred A, Schreiber G. Transthyretin expression in the rat brain: effect of thyroid functional state and role in thyroxine transport. Brain Res 1993;632:114-20.
31. Ramalingam M, Kim SJ. Mechanisms of action of brain insulin against neurodegenerative diseases. J Neural Transm 2014;121:611-26.
32. Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther 2012;136:82-93.
33. Kalra SP, Kalra PS. Neuroendocrine control of energy homeostasis: update on new insights. Prog Brain Res 2010;181:17-33.
34. Pan W, Kastin AJ. Adipokines and the blood-brain barrier. Peptides 2007;28:1317-30.
35. Banks WA. The blood-brain barrier as a cause of obesity. Curr Pharm Des 2008;14:1606-14.
36. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 2000;21:330-48.
37. Coculescu M. Blood-brain barrier for human growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 1999;12:113-24.
38. Pan W, Yu Y, Cain CM, Nyberg F, Couraud PO, Kastin AJ. Permeation of growth hormone across the blood-brain barrier. Endocrinology 2005;146:4898-904.
39. Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 2005;11:973-84.
40. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995;2:241-8.
41. Pan W, Kastin AJ. Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr Pharm Des 2003;9: 827-31.
42. Sandoval KE, Witt KA. Age and 17-estradiol effects on bloodbrain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvasc Res 2011;81:198-205.
43. Witt KA, Sandoval KE. Steroids and the blood-brain barrier: therapeutic implications. Adv Pharmacol 2014;71:361-90.
44. Banks WA. Blood-brain barrier as a regulatory interface. Forum Nutr 2010;63:102-10.
45. Mahringer A, Fricker G. BCRP at the blood-brain barrier: genomic regulation by 17-estradiol. Mol Pharm 2010;7: 1835-47.
46. Shi J, Simpkins JW. 17 Beta-estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol 1997;272:E1016-22.